ETC
RCUS icon

Exchange Traded Concepts’s Arcus Biosciences RCUS Stock Holding History

Exchange Traded Concepts’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,922
Closed -$109K – 1484
2025
Q1 		$109K Buy
13,922
+4,013
+40% +$46.5K ﹤0.01% 1126
2024
Q4 		$148K Hold
9,909
– – ﹤0.01% 1060
2024
Q3 		$152K Sell
9,909
-1,954
-16% -$30.8K ﹤0.01% 1064
2024
Q2 		$181K Sell
11,863
-3,690
-24% -$59.6K ﹤0.01% 886
2024
Q1 		$294K Buy
15,553
+8,737
+128% +$151K 0.01% 803
2023
Q4 		$130K Buy
6,816
+1,729
+34% +$27.6K ﹤0.01% 853
2023
Q3 		$91.3K Sell
5,087
-1,888
-27% -$37.9K ﹤0.01% 932
2023
Q2 		$142K Buy
+6,975
New +$133K ﹤0.01% 858
2023
Q1 		– Sell
-28,445
Closed -$588K – 1255
2022
Q4 		$588K Buy
28,445
+948
+3% +$26.1K 0.02% 475
2022
Q3 		$719K Buy
+27,497
New +$727K 0.02% 315

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Exchange Traded Concepts's RCUS Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Arcus Biosciences (RCUS) in Q2 2025, closing a stake of 13,922 shares — an estimated $109K sold.

Exchange Traded Concepts first reported a position in RCUS in Q3 2022 and held it in 10 quarters. The position peaked at $719K in Q3 2022. 185 funds tracked by Wall St. Rank hold RCUS as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Arcus Biosciences position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 13,922 Arcus Biosciences shares in Q2 2025, an estimated $109K.
  • Exchange Traded Concepts first reported a position in Arcus Biosciences in Q3 2022 and held it in 10 quarters.
  • Exchange Traded Concepts's Arcus Biosciences position peaked at $719K in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.